In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Ralliant Corp trades at a 55% premium to a highly confident fair value of $31.26, indicating potential overvaluation. Financial health scores reveal poor profitability and efficiency with moderate leverage and growth, increasing investment risk. Monte Carlo analysis shows a 100% downside risk below current price, underscoring volatility and downside exposure.